| Code | Description | Claims | Beneficiaries | Total Paid |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
40,784 |
36,801 |
$12.33M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
25,685 |
22,534 |
$11.52M |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
22,506 |
21,120 |
$4.45M |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
7,332 |
6,824 |
$4.07M |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
26,051 |
23,407 |
$3.30M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
4,309 |
3,938 |
$2.87M |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
9,231 |
8,725 |
$1.60M |
| 99291 |
Critical care, evaluation and management of the critically ill patient, first 30-74 minutes |
1,160 |
1,074 |
$1.23M |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
11,801 |
9,784 |
$1.21M |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
3,974 |
3,741 |
$907K |
| 59025 |
Fetal non-stress test |
4,412 |
2,649 |
$857K |
| G0378 |
Hospital observation service, per hour |
4,544 |
2,133 |
$705K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
26,437 |
22,990 |
$646K |
| 70450 |
Computed tomography, head or brain; without contrast material |
8,523 |
7,733 |
$448K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
3,702 |
2,035 |
$442K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
9,623 |
3,374 |
$321K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
1,183 |
1,158 |
$229K |
| 78452 |
Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress |
308 |
287 |
$197K |
| 66984 |
Extracapsular cataract removal with insertion of intraocular lens prosthesis |
296 |
288 |
$153K |
| 70553 |
Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences |
252 |
241 |
$147K |
| 71045 |
Radiologic examination, chest; single view |
20,335 |
18,039 |
$143K |
| 86900 |
|
2,594 |
2,250 |
$143K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
4,348 |
3,677 |
$135K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
1,026 |
978 |
$129K |
| A4649 |
Surgical supply; miscellaneous |
1,842 |
1,305 |
$118K |
| 41899 |
Unlisted procedure, dentoalveolar structures |
144 |
142 |
$109K |
| 10060 |
|
905 |
870 |
$96K |
| 12001 |
|
873 |
829 |
$95K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
1,802 |
1,642 |
$87K |
| 0002A |
|
2,279 |
2,172 |
$86K |
| 71046 |
Radiologic examination, chest; 2 views |
7,733 |
7,364 |
$85K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
8,938 |
8,147 |
$80K |
| 0001A |
|
2,123 |
2,042 |
$79K |
| 70551 |
Magnetic resonance imaging, brain; without contrast material |
571 |
536 |
$78K |
| 73610 |
|
2,482 |
2,171 |
$73K |
| 12002 |
|
867 |
835 |
$73K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
2,912 |
2,747 |
$72K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
3,544 |
2,738 |
$71K |
| 73562 |
|
2,943 |
2,492 |
$69K |
| 73630 |
|
2,619 |
2,346 |
$68K |
| 76801 |
|
1,183 |
1,062 |
$67K |
| 76830 |
Ultrasound, transvaginal |
1,631 |
1,571 |
$65K |
| C1713 |
Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) |
118 |
105 |
$64K |
| 73030 |
|
2,673 |
2,374 |
$63K |
| 73110 |
|
2,291 |
1,953 |
$56K |
| 73130 |
|
2,433 |
2,111 |
$50K |
| 76770 |
|
880 |
822 |
$48K |
| 97161 |
|
646 |
606 |
$46K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
1,962 |
1,754 |
$45K |
| 93971 |
|
1,171 |
1,107 |
$43K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
2,849 |
2,619 |
$43K |
| 94060 |
|
375 |
371 |
$40K |
| 70486 |
|
858 |
806 |
$39K |
| P9016 |
Red blood cells, leukocytes reduced, each unit |
68 |
51 |
$38K |
| 72131 |
|
1,278 |
1,191 |
$37K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
9,497 |
7,467 |
$36K |
| 87634 |
|
3,460 |
3,309 |
$36K |
| 73080 |
|
1,235 |
1,085 |
$35K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
1,010 |
552 |
$33K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
1,323 |
1,196 |
$33K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
1,222 |
1,150 |
$33K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
4,123 |
1,669 |
$31K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
2,041 |
1,646 |
$31K |
| 74018 |
|
657 |
603 |
$30K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
1,928 |
1,787 |
$30K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
1,237 |
1,156 |
$29K |
| 73502 |
|
1,378 |
1,268 |
$29K |
| 86920 |
|
188 |
154 |
$27K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
3,034 |
2,058 |
$25K |
| C1889 |
Implantable/insertable device, not otherwise classified |
545 |
506 |
$23K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
20,004 |
16,120 |
$23K |
| 71250 |
|
468 |
453 |
$23K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
5,045 |
4,402 |
$22K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
86 |
81 |
$22K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
1,308 |
1,252 |
$22K |
| 73140 |
|
868 |
745 |
$21K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
27,516 |
23,041 |
$18K |
| 73590 |
|
1,113 |
968 |
$18K |
| 73564 |
|
453 |
349 |
$15K |
| 73090 |
|
577 |
486 |
$14K |
| 76536 |
|
150 |
145 |
$13K |
| 97162 |
|
156 |
149 |
$12K |
| 71271 |
|
111 |
110 |
$12K |
| C8929 |
Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, complete, with spectral doppler echocardiography, and with color flow doppler echocardiography |
88 |
88 |
$11K |
| 94726 |
|
406 |
401 |
$11K |
| 71101 |
|
400 |
378 |
$11K |
| 96376 |
|
3,510 |
2,882 |
$10K |
| J0897 |
Injection, denosumab, 1 mg |
12 |
12 |
$9K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
1,717 |
1,650 |
$9K |
| 88307 |
|
27 |
27 |
$9K |
| 93970 |
|
69 |
68 |
$8K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
5,214 |
4,285 |
$8K |
| M0222 |
Intravenous injection, bebtelovimab, includes injection and post administration monitoring |
44 |
40 |
$8K |
| 45380 |
Colonoscopy, flexible; with biopsy, single or multiple |
14 |
12 |
$8K |
| 45378 |
Colonoscopy, flexible; diagnostic, including collection of specimen(s) |
12 |
12 |
$8K |
| 12011 |
|
93 |
91 |
$7K |
| 88342 |
|
145 |
140 |
$7K |
| 99215 |
Prolong outpt/office vis |
95 |
75 |
$7K |
| 72148 |
Magnetic resonance imaging, lumbar spine; without contrast material |
43 |
39 |
$7K |
| 73721 |
Magnetic resonance imaging, any joint of lower extremity; without contrast material |
25 |
25 |
$7K |
| 93880 |
|
26 |
26 |
$6K |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
118 |
117 |
$5K |
| 76870 |
|
85 |
77 |
$5K |
| 93925 |
|
12 |
12 |
$5K |
| 70491 |
|
63 |
62 |
$5K |
| 96523 |
|
176 |
134 |
$4K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
689 |
467 |
$4K |
| 97112 |
Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination |
174 |
100 |
$4K |
| 80053 |
Comprehensive metabolic panel |
48,587 |
41,290 |
$4K |
| Q5101 |
Injection, filgrastim-sndz, biosimilar, (zarxio), 1 microgram |
229 |
67 |
$3K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
17,746 |
13,930 |
$3K |
| 83880 |
|
2,113 |
1,899 |
$3K |
| 96415 |
|
851 |
463 |
$3K |
| 86901 |
|
3,373 |
2,960 |
$3K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
51 |
49 |
$3K |
| 93351 |
|
13 |
13 |
$3K |
| 76815 |
Ultrasound, pregnant uterus, real time with image documentation, limited |
179 |
123 |
$2K |
| 74174 |
|
13 |
13 |
$2K |
| 72170 |
|
56 |
51 |
$2K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
8,626 |
4,511 |
$2K |
| 72110 |
|
56 |
55 |
$1K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
786 |
717 |
$1K |
| 97165 |
|
29 |
25 |
$1K |
| 72128 |
|
110 |
97 |
$1K |
| 93017 |
|
320 |
299 |
$1K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
138 |
128 |
$1K |
| 84702 |
|
1,817 |
1,593 |
$1K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
53,492 |
44,187 |
$967.79 |
| J0171 |
Injection, adrenalin, epinephrine, 0.1 mg |
1,363 |
909 |
$917.65 |
| 93976 |
|
126 |
119 |
$900.38 |
| 87420 |
|
882 |
822 |
$851.02 |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
1,194 |
1,125 |
$751.61 |
| 87186 |
|
4,869 |
4,554 |
$702.75 |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
469 |
398 |
$527.58 |
| 72100 |
|
52 |
50 |
$516.84 |
| 76000 |
|
256 |
221 |
$444.58 |
| 90715 |
|
2,501 |
2,350 |
$401.16 |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
11,736 |
10,692 |
$386.62 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
1,972 |
1,854 |
$356.87 |
| 84703 |
|
14,628 |
13,016 |
$339.82 |
| 87077 |
|
5,413 |
5,082 |
$330.74 |
| 80048 |
Basic metabolic panel (calcium, ionized) |
4,624 |
3,849 |
$319.69 |
| 81001 |
|
34,428 |
30,331 |
$302.30 |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
775 |
695 |
$263.80 |
| 83690 |
|
11,593 |
10,388 |
$261.43 |
| 73521 |
|
14 |
14 |
$252.71 |
| 80329 |
|
996 |
505 |
$252.42 |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
32 |
27 |
$204.74 |
| 72192 |
|
16 |
13 |
$194.84 |
| 73552 |
|
13 |
13 |
$164.33 |
| C1769 |
Guide wire |
1,247 |
1,106 |
$161.78 |
| 70496 |
|
14 |
14 |
$147.41 |
| 84484 |
|
12,632 |
9,304 |
$138.48 |
| 94375 |
|
28 |
28 |
$125.05 |
| 84443 |
Thyroid stimulating hormone (TSH) |
3,759 |
3,437 |
$120.62 |
| 83605 |
|
5,997 |
4,900 |
$99.66 |
| 84145 |
|
2,370 |
2,175 |
$87.86 |
| 87040 |
|
7,235 |
4,074 |
$82.33 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
11,894 |
10,953 |
$77.83 |
| 83735 |
|
7,932 |
6,779 |
$66.10 |
| 87070 |
|
1,849 |
1,722 |
$64.35 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
2,029 |
1,984 |
$61.12 |
| 96367 |
|
2,440 |
1,399 |
$56.47 |
| 85379 |
|
2,158 |
2,056 |
$53.50 |
| 85610 |
|
8,565 |
7,763 |
$49.76 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
20,843 |
13,095 |
$48.07 |
| 70498 |
|
25 |
25 |
$46.00 |
| 87081 |
|
1,692 |
1,646 |
$45.78 |
| 85730 |
|
5,300 |
4,851 |
$38.39 |
| 73660 |
|
39 |
38 |
$37.69 |
| 36591 |
|
20 |
12 |
$35.82 |
| J0330 |
Injection, succinylcholine chloride, up to 20 mg |
525 |
454 |
$34.80 |
| 86140 |
|
1,778 |
1,678 |
$34.00 |
| 82805 |
|
117 |
103 |
$27.85 |
| A9575 |
Injection, gadoterate meglumine, 0.1 ml |
359 |
345 |
$27.56 |
| 80320 |
|
809 |
708 |
$21.37 |
| 84100 |
|
2,893 |
2,323 |
$18.50 |
| 87088 |
|
860 |
811 |
$15.70 |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
3,127 |
2,330 |
$15.32 |
| 96402 |
|
189 |
157 |
$15.06 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
12,271 |
8,680 |
$13.66 |
| 86850 |
|
2,528 |
2,208 |
$13.08 |
| 80061 |
Lipid panel |
12 |
12 |
$11.54 |
| J3490 |
Unclassified drugs |
490 |
330 |
$11.54 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
6,581 |
3,271 |
$11.30 |
| 87205 |
|
1,458 |
1,366 |
$10.44 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
4,498 |
3,957 |
$9.66 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
5,969 |
4,327 |
$6.28 |
| 85651 |
|
475 |
456 |
$5.53 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
5,960 |
4,385 |
$5.00 |
| A9270 |
Non-covered item or service |
779 |
314 |
$3.00 |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
190 |
126 |
$1.61 |
| J7030 |
Infusion, normal saline solution , 1000 cc |
1,048 |
789 |
$1.52 |
| J2060 |
Injection, lorazepam, 2 mg |
2,657 |
1,988 |
$1.28 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
3,744 |
2,306 |
$1.25 |
| J0131 |
Injection, acetaminophen, not otherwise specified,10 mg |
1,673 |
1,410 |
$1.00 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
15,446 |
9,096 |
$0.75 |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
2,440 |
2,221 |
$0.62 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
5,115 |
3,759 |
$0.13 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
2,064 |
1,775 |
$0.00 |
| J1453 |
Injection, fosaprepitant, 1 mg |
452 |
255 |
$0.00 |
| C9113 |
Injection, pantoprazole sodium, per vial |
1,447 |
1,134 |
$0.00 |
| J2919 |
Injection, methylprednisolone sodium succinate, 5 mg |
239 |
208 |
$0.00 |
| J3105 |
Injection, terbutaline sulfate, up to 1 mg |
298 |
172 |
$0.00 |
| C1894 |
Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser |
962 |
850 |
$0.00 |
| 80305 |
|
758 |
694 |
$0.00 |
| A4565 |
Slings |
60 |
60 |
$0.00 |
| 94729 |
|
411 |
405 |
$0.00 |
| 82565 |
|
144 |
138 |
$0.00 |
| J1644 |
Injection, heparin sodium, per 1000 units |
178 |
93 |
$0.00 |
| 96417 |
|
456 |
292 |
$0.00 |
| C1887 |
Catheter, guiding (may include infusion/perfusion capability) |
271 |
228 |
$0.00 |
| J0780 |
Injection, prochlorperazine, up to 10 mg |
1,321 |
1,174 |
$0.00 |
| A6445 |
Conforming bandage, non-elastic, knitted/woven, sterile, width less than three inches, per yard |
25 |
25 |
$0.00 |
| J0134 |
Injection, acetaminophen (fresenius kabi), not therapeutically equivalent to j0131, 10 mg |
1,490 |
1,365 |
$0.00 |
| 91300 |
|
4,417 |
3,777 |
$0.00 |
| J1171 |
Injection, hydromorphone, 0.1 mg |
219 |
75 |
$0.00 |
| J3370 |
Injection, vancomycin hcl, 500 mg |
458 |
293 |
$0.00 |
| 84550 |
|
132 |
111 |
$0.00 |
| A6446 |
Conforming bandage, non-elastic, knitted/woven, sterile, width greater than or equal to three inches and less than five inches, per yard |
52 |
49 |
$0.00 |
| 87075 |
|
85 |
79 |
$0.00 |
| 29125 |
|
41 |
41 |
$0.00 |
| 77336 |
|
73 |
26 |
$0.00 |
| S0028 |
Injection, famotidine, 20 mg |
96 |
94 |
$0.00 |
| 87210 |
|
12 |
12 |
$0.00 |
| Q0243 |
Injection, casirivimab and imdevimab, 2400 mg |
36 |
29 |
$0.00 |
| A4314 |
Insertion tray with drainage bag with indwelling catheter, foley type, two-way latex with coating (teflon, silicone, silicone elastomer or hydrophilic, etc.) |
26 |
24 |
$0.00 |
| A4353 |
Intermittent urinary catheter, with insertion supplies |
48 |
45 |
$0.00 |
| C1758 |
Catheter, ureteral |
13 |
13 |
$0.00 |
| 88312 |
|
29 |
27 |
$0.00 |
| J1953 |
Injection, levetiracetam, 10 mg |
34 |
26 |
$0.00 |
| 80076 |
|
12 |
12 |
$0.00 |
| 87045 |
|
14 |
14 |
$0.00 |
| 87899 |
|
26 |
13 |
$0.00 |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
2,050 |
1,641 |
$0.00 |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
434 |
251 |
$0.00 |
| V2632 |
Posterior chamber intraocular lens |
267 |
259 |
$0.00 |
| J1630 |
Injection, haloperidol, up to 5 mg |
754 |
536 |
$0.00 |
| J1815 |
Injection, insulin, per 5 units |
365 |
251 |
$0.00 |
| 88304 |
|
693 |
629 |
$0.00 |
| J1940 |
Injection, furosemide, up to 20 mg |
1,195 |
909 |
$0.00 |
| 82550 |
|
955 |
887 |
$0.00 |
| J2469 |
Injection, palonosetron hcl, 25 mcg |
854 |
487 |
$0.00 |
| J7050 |
Infusion, normal saline solution, 250 cc |
953 |
284 |
$0.00 |
| A9500 |
Technetium tc-99m sestamibi, diagnostic, per study dose |
261 |
251 |
$0.00 |
| 88341 |
|
14 |
13 |
$0.00 |
| J2370 |
Injection, phenylephrine hcl, up to 1 ml |
325 |
286 |
$0.00 |
| 85027 |
|
95 |
89 |
$0.00 |
| J2785 |
Injection, regadenoson, 0.1 mg |
211 |
195 |
$0.00 |
| J0456 |
Injection, azithromycin, 500 mg |
14 |
14 |
$0.00 |
| J2543 |
Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) |
869 |
585 |
$0.00 |
| 36430 |
|
27 |
26 |
$0.00 |
| 73060 |
|
13 |
12 |
$0.00 |
| Q3014 |
Telehealth originating site facility fee |
155 |
138 |
$0.00 |
| L4350 |
Ankle control orthosis, stirrup style, rigid, includes any type interface (e.g., pneumatic, gel), prefabricated, off-the-shelf |
13 |
13 |
$0.00 |
| J2371 |
Injection, phenylephrine hydrochloride, 20 micrograms |
250 |
234 |
$0.00 |
| J3480 |
Injection, potassium chloride, per 2 meq |
39 |
27 |
$0.00 |
| 97035 |
|
146 |
81 |
$0.00 |
| J2470 |
Injection, pantoprazole sodium, 40 mg |
119 |
108 |
$0.00 |
| J3360 |
Injection, diazepam, up to 5 mg |
147 |
71 |
$0.00 |
| 0031A |
|
18 |
16 |
$0.00 |
| Q0222 |
Injection, bebtelovimab, 175 mg |
74 |
69 |
$0.00 |
| 87046 |
|
14 |
14 |
$0.00 |
| J2795 |
Injection, ropivacaine hydrochloride, 1 mg |
15 |
12 |
$0.00 |
| 87015 |
|
13 |
13 |
$0.00 |
| 74022 |
|
15 |
13 |
$0.00 |
| J0360 |
Injection, hydralazine hcl, up to 20 mg |
14 |
12 |
$0.00 |
| J2003 |
Injection, lidocaine hydrochloride, 1 mg |
51 |
43 |
$0.00 |
| M0243 |
Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring |
41 |
34 |
$0.00 |
| J3590 |
Unclassified biologics |
37 |
30 |
$0.00 |
| 91303 |
|
22 |
21 |
$0.00 |
| A4320 |
Irrigation tray with bulb or piston syringe, any purpose |
23 |
17 |
$0.00 |